DOI: 10.14264/uql.2015.698
|View full text |Cite
|
Sign up to set email alerts
|

Development and application of monoclonal antibodies to Chikungunya virus proteins

Abstract: Chikungunya virus (CHIKV) is a mosquito-borne pathogen that causes arthritic disease in humans and is considered a serious health threat in regions where competent mosquito vectors are prevalent. The recent CHIKV epidemic (2004-2014) has resulted in an estimated 1.4-6.5 million cases, involving more than 40 countries. There are no commercially licensed human vaccines available against infection with this re-emerging alphavirus. Treatment of CHIKV rheumatic disease usually involves the use of analgesics and/or … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 192 publications
(420 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?